In a previous study, we showed that apoA2-ATQ/AT is significantly reduced in patients with pancreatic cancer because the alteration of pancreatic exocrine functions causes aberrant processing of apoA2 dimers. Here, APOA2 is linked to pancreatic neoplasm.